---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-227590"
form_type: "8-K"
ticker: "FULC"
cik: "0001680581"
company_name: "Fulcrum Therapeutics, Inc."
filed_at: "2022-08-23T23:59:59+00:00"
generated_at: "2026-06-23T22:01:46.375399+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Fulcrum Therapeutics completes $80.9M underwritten public offering

## Summary
- Underwriters exercised option to buy 1,438,618 additional shares at $7.82/share.
- Additional net proceeds of ~$10.6M; total net proceeds ~$80.9M after discounts and expenses.
- Overallotment option closed on August 23, 2022.

## SEC filing metadata
- accession: 0001193125-22-227590
- form_type: 8-K
- ticker: FULC
- cik: 0001680581
- company_name: Fulcrum Therapeutics, Inc.
- filed_at: 2022-08-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1680581/000119312522227590/0001193125-22-227590-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1680581/000119312522227590/d353295d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-227590
- JSON: https://secwatch.observer/filing/0001193125-22-227590.json
- Plain text: https://secwatch.observer/filing/0001193125-22-227590.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.